MRI-based habitat radiomics for preoperative prediction of axillary pathological complete response in breast cancer after neoadjuvant therapy: a multicenter study - Report - MDSpire

MRI-based habitat radiomics for preoperative prediction of axillary pathological complete response in breast cancer after neoadjuvant therapy: a multicenter study

  • By

  • Lei Ma

  • Shunian Li

  • Ziwei Cao

  • Jun Liao

  • Mengting Xu

  • Chuanjian Lv

  • Chunmiao Xu

  • Hongna Tan

  • May 13, 2026

  • 0 min

Share

Clinical Report: Preoperative Prediction of Axillary Pathological Complete Response

Overview

{'add': 'Specify traditional models compared to the nomogram.'}

Background

{'add': 'Include statistics or references for apCR rate variability.'}

Data Highlights

{'clarify': 'Define AUC as area under the curve.'}

Key Findings

{'add': 'Detail the calibration analysis methodology.'}

Clinical Implications

{'add': 'Discuss limitations of the nomogram in clinical settings.'}

Conclusion

{'add': "Emphasize the findings' relevance to current practices."}

Related Resources & Content

  1. European Radiology, 2025 -- Assessment of Primary Tumour Changes on Breast MRI as an Indicator of Axillary Pathological Response in Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer
  2. European Radiology, 2025 -- Assessing Residual Axillary Disease Following Neoadjuvant Therapy in Breast Cancer Through Initial MRI and Ultrasound Evaluations
  3. European Radiology, 2025 -- Radiomics Utilizing Deep Learning Fails to Enhance Prediction of Residual Cancer Burden Following Chemotherapy in the LIMA Breast MRI Study
  4. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up, 2025
  5. European Radiology — Utilizing Whole-Tumor Texture Analysis of Multisequence MRI to Forecast Pathological Complete Response in Soft Tissue Sarcoma Following Neoadjuvant Radiotherapy and Targeted Therapy
  6. Omitting Regional Nodal Irradiation after Response to Neoadjuvant Therapy
  7. A non-invasive artificial intelligence model for identifying axillary pathological complete response to neoadjuvant chemotherapy in breast cancer
  8. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up - ScienceDirect

Original Source(s)

Related Content